ResonanceMusic for Orchestra Vol. 1 is an orchestral album by the German-based alternative electronic band VNV Nation, with the Deutsches Filmorchester Babelsberg, released on May 15, 2015 on VNV's own Anachron Sounds label. All songs are from their back catalogue, arranged for orchestra and voice.
It was released on CD and digital formats, as well as a limited edition 6 x 10" vinyl box set. Both the limited edition vinyl and iTunes digital versions have exclusive bonus tracks, both of songs originally from their previous album Transnational.[1]
It was VNV Nation's highest charting release at the time, reaching number 7 in the German charts (two weeks) and no. 73 in the Austrian charts (1 week),[2] and number 3 (1 week) on Billboard's "Classical Crossover" Albums chart.[3]
On the 11th November 2012, VNV Nation played at the first Gothic meets Klassik in Leipzig.[4] This set was accompanied by a full symphony orchestra. It marked the first time VNV Nation had done a set like this. The show was recorded for release, but the recorded audio was unusable. As a result, Ronan began work with the arranger, Conrad Oleak, on plans for an album, later titled Resonance, of VNV Nation songs, scored for orchestra. As well as the original eight songs performed, there were an additional five songs re-written for orchestra.[5] The songs 'Nova (Largo)' and 'Teleconnect, Part 2' were recorded with a piano and string trio ensemble.
The site is secure.
The ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The study of ultra-small paramagnetic gadolinium oxide (Gd2O3) nanoparticles (NPs) as in vivo positive (T1) magnetic resonance imaging (MRI) contrast agents is one of the most attractive fields in nanomedicine. The performance of the Gd2O3 NP imaging agents depends on the surface-coating materials. In this study, poly(methyl vinyl ether-alt-maleic acid) (PMVEMA) was used as a surface-coating polymer. The PMVEMA-coated paramagnetic ultra-small Gd2O3 NPs with an average particle diameter of 1.9 nm were synthesized using the one-pot polyol method. They exhibited excellent colloidal stability in water and good biocompatibility. They also showed a very high longitudinal water proton spin relaxivity (r1) value of 36.2 s-1mM-1 (r2/r1 = 2.0; r2 = transverse water proton spin relaxivity) under a 3.0 tesla MR field which is approximately 10 times higher than the r1 values of commercial molecular contrast agents. High positive contrast enhancements were observed in in vivo T1 MR images after intravenous administration of the NP solution sample, demonstrating its potential as a T1 MRI contrast agent.
Magnetic resonance imaging (MRI) is a medical imaging technique that uses a large magnet and radio waves to create clear pictures of internal body structures. MRI provides excellent contrast between the different soft tissues of the body and is especially useful in imaging the brain, spine, joints, muscles and other structures. The superior resolution of the images and advancing technology is rapidly increasing the variety of exams an MRI technologist will perform.
MRI technologists are educated and trained to work with patients and other health care team members to obtain high-quality images safely and effectively. MRI offers procedures that are helpful to a broad span of medical specialties. These specialties include neurology, sports medicine, cardiology, pediatrics and more.
Saint Louis University's Bachelor of Science in Magnetic Resonance Imaging prepares graduates for entry-level positions as MRI technologists. The program includes all basic sciences and an intensive MRI curriculum that includes approximately 1,000 hours of clinical practicum. Upon successful completion of the program, graduates are eligible for national certification to become registered MRI technologists/radiologic technologists (MR).
Students in SLU's MRI degree program have opportunities to conduct research and produce projects and papers that are acceptable for publication and could be presented at professional conferences. MRI students are encouraged to join and participate in the American Society of Radiologic Technologists (ASRT).
Some jobs are classified as traveling jobs where the employee provides temporary help to short-staffed departments for a while. These technologists regularly travel, with the length of stay and location varying.
The magnetic resonance imaging program at Saint Louis University is fully accredited by the Joint Review Committee on Education in Radiologic Technology (JRCERT), having been awarded an eight-year accreditation. The program's next scheduled accreditation review is in the third quarter of 2027.
For more information about the SLU magnetic resonance imaging program's goals, program outcomes, certification examination pass rates, job placement rates, technical standards and program-specific costs, please review the additional accreditation information document.
This roadmap should not be used in the place of regular academic advising appointments. All students are encouraged to meet with their advisor/mentor each semester. Requirements, course availability and sequencing are subject to change.
To be considered for the second baccalaureate degree option, the applicant must have satisfactorily completed a baccalaureate degree, with a minimum GPA of 2.7 (on a 4.0 scale), including the prerequisite courses listed above.
The applicant must show satisfactory evidence of good character and physical ability to perform the functions of magnetic resonance technologists. All applicants must meet the professional performance and technical standards required by the profession. Students must also successfully complete a drug screen and criminal background check prior to the start of clinical rotations.
The page could not be loaded. The CMS.gov Web site currently does not fully support browsers with"JavaScript" disabled. Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with"JavaScript" disabled.Instructions for enabling "JavaScript" can be found here.Please note that if you choose to continue without enabling "JavaScript" certain functionalities on this website may not be available.
The Centers for Medicare & Medicaid Services (CMS) is reconsidering our national coverage determination at section 220.2 of the Medicare National Coverage Determinations Manual, specifically the Coverage with Evidence Development (CED) requirement (section 220.2(C)(1)). We determined that the evidence is sufficient to conclude that magnetic resonance imaging (MRI) for Medicare beneficiaries with an implanted pacemaker (PM), implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy pacemaker (CRT-P), or cardiac resynchronization therapy defibrillator (CRT-D) is reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member under section 1862(a)(1)(A) of the Social Security Act under certain circumstances. Thus, we will modify our national coverage determination to eliminate the collection of additional information under the Coverage with Evidence Development paradigm under section 1862(a)(1)(E) of the Social Security Act.
CMS recognizes that the tracking sheet informing the public that we are reconsidering coverage of MRI did not indicate our intention of only reconsidering the coverage with evidence development (CED) subsection (see 220.2(C)(1)) of 220.2 of the NCD Manual. The reason we were intending to only focus on section 220.2(C)(1) of the NCD manual was because there was a number of studies supporting MRI use for the indications in section 220(C)(1). Further, we recognize that there may be limitations to access as well as burden to patients and practitioners with the approved CED studies. We carefully reviewed all of the comments we received following the posting of the tracking sheet and note that several comments requested we expand to indications beyond our current NCD section 220.2(C)(1). We have addressed these comments in the public comment section of this NCA but did not make any changes to any section of the NCD except 220.2(C)(1) of the NCD manual (with corresponding changes to add covered indications in 220.2(B)(3) for alignment).
3a8082e126